These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16686808)

  • 1. The effect of pharmacy benefit design on patient-physician communication about costs.
    Shrank WH; Fox SA; Kirk A; Ettner SL; Cantrell CH; Glassman P; Asch SM
    J Gen Intern Med; 2006 Apr; 21(4):334-9. PubMed ID: 16686808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do the incentives in 3-tier pharmaceutical benefit plans operate as intended? Results from a physician leadership survey.
    Shrank WH; Young HN; Ettner SL; Glassman P; Asch SM; Kravitz RL
    Am J Manag Care; 2005 Jan; 11(1):16-22. PubMed ID: 15697096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicians' opinions about responsibility for patient out-of-pocket costs and formulary prescribing in two Midwestern states.
    Khan S; Sylvester R; Scott D; Pitts B
    J Manag Care Pharm; 2008 Oct; 14(8):780-9. PubMed ID: 18983207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of the use and costs of physician office visits and prescription drugs to travel distance and increases in member cost share.
    Cecil WT; Barnes J; Shea T; Coulter SL
    J Manag Care Pharm; 2006 Oct; 12(8):665-76. PubMed ID: 17269845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicians' perceived knowledge of and responsibility for managing patients' out-of-pocket costs for prescription drugs.
    Shrank WH; Asch SM; Joseph GJ; Young HN; Ettner SL; Kholodenko Y; Glassman P; Kravitz RL
    Ann Pharmacother; 2006 Sep; 40(9):1534-40. PubMed ID: 16912246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incentive formularies and changes in prescription drug spending.
    Landon BE; Rosenthal MB; Normand SL; Spettell C; Lessler A; Underwood HR; Newhouse JP
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):360-9. PubMed ID: 17567237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consumer response to dual incentives under multitiered prescription drug formularies.
    Gilman BH; Kautter J
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):353-9. PubMed ID: 17567236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicians' perceptions of relevant prescription drug costs: do costs to the individual patient or to the population matter most?
    Shrank WH; Joseph GJ; Choudhry NK; Young HN; Ettner SL; Glassman P; Asch SM; Kravitz RL
    Am J Manag Care; 2006 Sep; 12(9):545-51. PubMed ID: 16961443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Employer drug benefit plans and spending on prescription drugs.
    Joyce GF; Escarce JJ; Solomon MD; Goldman DP
    JAMA; 2002 Oct; 288(14):1733-9. PubMed ID: 12365957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefit plan design and prescription drug utilization among asthmatics: do patient copayments matter?
    Crown WH; Berndt ER; Baser O; Finkelstein SN; Witt WP; Maguire J; Haver KE
    Front Health Policy Res; 2004; 7():95-127. PubMed ID: 15612337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of incentive-based formularies on prescription-drug utilization and spending.
    Huskamp HA; Deverka PA; Epstein AM; Epstein RS; McGuigan KA; Frank RG
    N Engl J Med; 2003 Dec; 349(23):2224-32. PubMed ID: 14657430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of Physician Estimates of Out-of-Pocket Costs for Medication Filling.
    Sloan CE; Millo L; Gutterman S; Ubel PA
    JAMA Netw Open; 2021 Nov; 4(11):e2133188. PubMed ID: 34739059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-physician communication about out-of-pocket costs.
    Alexander GC; Casalino LP; Meltzer DO
    JAMA; 2003 Aug; 290(7):953-8. PubMed ID: 12928475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial differences in beliefs of physician prescribing practices for low-cost pharmacy options.
    Dalawari P; Patel NM; Bzdawka W; Petrone J; Liou V; Armbrecht E
    J Emerg Med; 2014 Mar; 46(3):396-403. PubMed ID: 24126066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dutch GPs' perceptions: the influence of out-of-pocket costs on prescribing.
    Kasje WN; Timmer JW; Boendermaker PM; Haaijer-Ruskamp FM
    Soc Sci Med; 2002 Nov; 55(9):1571-8. PubMed ID: 12297243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.
    Tseng CW; Brook RH; Keeler E; Mangione CM
    JAMA; 2003 Jul; 290(2):222-7. PubMed ID: 12851277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of tiered prescription copayments on the use of preferred brand medications.
    Rector TS; Finch MD; Danzon PM; Pauly MV; Manda BS
    Med Care; 2003 Mar; 41(3):398-406. PubMed ID: 12618643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between older adults' knowledge of their drug coverage and medication cost problems.
    Piette JD; Heisler M
    J Am Geriatr Soc; 2006 Jan; 54(1):91-6. PubMed ID: 16420203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of pharmacy benefit design on prescription drug utilization: a fixed effects analysis of plan sponsor data.
    Roebuck MC; Liberman JN
    Health Serv Res; 2009 Jun; 44(3):988-1009. PubMed ID: 19187183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence.
    Shirneshan E; Kyrychenko P; Matlin OS; Avila JP; Brennan TA; Shrank WH
    J Clin Pharm Ther; 2016 Feb; 41(1):64-9. PubMed ID: 26778812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.